OCTOBER - 20225TECH OUTLOOKCOMPANY OF THE YEARHow Allogeneic Stem Cell Therapies Can Transform Prospects in Inherited Retinal DiseasesGil Carrasquinho, VP Head of Cell Therapy, Santen23The Value of Technology in PharmacovigilanceAnnette Stemhagen,Senior Vice President,UBC21Data Science in R&D: It Is about Culture!Philippe Marc,Executive Director,Global Head of Integrated Data Science,Novartis27COVID-19 as a Catalyst for Digital Transformation of Clinical Research:Are We There Yet?Dr. Ammar Raza, Regional Medical Director- Middle East and Africa, Allergan Aesthetics,an AbbVie company, Dubai28LAST WORDImproving Drug Shortage ManagementAshley L. Pappas, PharmD, MHA, Director of Pharmacy Medication Management and Optimization, Pharmacy Analytics and Outcomes Pharmacy Services, UNC Health;Greg Norsten, PharmD, PGY2 Health-System Pharmacy Administration andLeadership Resident, UNC Health30HiROKaren Chu,CEO Wendy Mach,CCO18CXO INSIGHTSProviding a Platform to Empower Better, Faster, and Economical Clinical Trials
< Page 4 | Page 6 >